Indian pharma industry manufacturing and supply chain disruptions amid Covid-19 crisis
By MYBRANDBOOK
India's coronavirus (Covid-19) lockdown has impacted the manufacturing and supply chain operations of pharmaceuticals despite pharmaceutical manufacturing being considered an essential service and excluded from the lockdown. However, government initiatives have helped to minimize disruptions to pharmaceutical manufacturing and the supply chain, says GlobalData, a leading data and analytics company.
The issues faced by the pharmaceutical industry include slowdown in the production due to lack of manpower, difficulties with the supply of raw materials, transportation, logistics and closure of ancillary companies involved in the packaging and printing. Additionally, transportation problems have led to supply issues of drugs such as hydroxychloroquine (HCQS) needed for Covid-19 patients, insulin and other refrigerated medicines, in some parts of the country.
Nag Madhavi, Pharma Analyst at GlobalData, says: “It is important that Indian drug manufacturing is not disrupted due to the lockdown. India is a key player in the global generic drug industry and supply disruptions will affect the exports. Furthermore, several of these generic drugs have been repurposed for the treatment and prophylaxis of Covid-19 which has increased India’s role in the global pharmaceutical market.”
The Government of India has undertaken different measures to prevent disruption in the pharmaceutical industry. In order to monitor the real time status of the transportation and delivery of essential commodities, a control room has been set up by the Department for Promotion of Industry and Internal Trade (DPIIT). The state drug controllers were instructed by the Drug Controller General of India (DCGI) to provide operational data on a daily basis.
In addition, the Indian Postal Service is also being involved in the transportation of pharmaceuticals and medical equipment. The National Pharmaceutical Pricing Authority (NPPA) is working on developing information technology platform to track the hydroxychloroquine (HCQS) stock, which is considered as an important drug for the treatment of healthcare workers and patients during the Covid-19 outbreak.
Madhavi concludes: “The pandemic has created immense pressure at all levels of society including the government and the corporate sector. However, the government’s intervention has helped minimize the majority of the challenges being faced by the pharmaceutical industry and improving the situation at the manufacturing and supply chain level. Such strategies will help India to cater to both the domestic and the global pharmaceutical market, during these difficult times.”
Singapore to remove One-Time Passwords from Bank Accounts
According to the Monetary Authority of Singapore, clients who utilise secur...
Is 375 million Airtel subscribers database breached?
When a hacker claims to have accessed and put up for sale a customer databa...
The government of India intends to construct a single portal f
A single portal will be launched by the Indian government to list all of it...
OpenAI offers GPT-4o, a faster model available to all users at
GPT-4o, a faster and more sophisticated AI model, is made available to all...
Icons Of India : Harsh Jain
Harsh Jain, the co-founder of Dream 11, the largest fantasy sports web...
Icons Of India : NEERAJ MITTAL
He started his career as an IAS Officer in 1992. He has held various a...
ICONS OF INDIA : RAJIV MEMANI
As Chair of the EY Global Emerging Markets Committee, Rajiv connects e...
IOCL - Indian Oil Corporation Ltd.
IOCL is India’s largest oil refining and marketing company ...
NPCI - National Payments Corporation of India
NPCI is an umbrella organization for operating retail payments and set...
NSE - National Stock Exchange
NSE is the leading stock exchange in India....
Indian Tech Talent Excelling The Tech World - Aneel Bhusri, CEO, Workday
Aneel Bhusri, Co-Founder and Executive Chair at Workday, has been a le...
Indian Tech Talent Excelling The Tech World - JAYASHREE ULLAL, President and CEO - Arista Network
Jayshree V. Ullal is a British-American billionaire businesswoman, ser...
Indian Tech Talent Excelling The Tech World - REVATHI ADVAITHI, CEO- Flex
Revathi Advaithi, the CEO of Flex, is a dynamic leader driving growth ...